1/16
08:00 am
eltx
Elicio Therapeutics Reports Inducement Grants
Medium
Report
Elicio Therapeutics Reports Inducement Grants
12/16
08:00 am
eltx
Elicio Therapeutics Reports Inducement Grants
Medium
Report
Elicio Therapeutics Reports Inducement Grants
12/11
10:00 am
eltx
Occam Global Strengthens Life Science Leadership with Transformative 2025
Low
Report
Occam Global Strengthens Life Science Leadership with Transformative 2025
12/11
08:27 am
eltx
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial [Yahoo! Finance]
Medium
Report
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial [Yahoo! Finance]
12/11
08:00 am
eltx
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
Medium
Report
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
11/19
08:00 am
eltx
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
Medium
Report
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
11/7
04:07 pm
eltx
Elicio Therapeutics: Running On Fumes, But A Definitive Readout Appears Imminent [Seeking Alpha]
Low
Report
Elicio Therapeutics: Running On Fumes, But A Definitive Readout Appears Imminent [Seeking Alpha]